Fundraising Fox
Intralytix
Baltimore, US · Maryland corporation
Find your way into Intralytix
Sign up to see every warm intro you have to Intralytix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Intralytix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AS
Alexander SulakvelidzeFounder · President and Chief Executive OfficerAlexander Sulakvelidze holds a Ph.D. and co-founded Intralytix in 1998, where he serves as President and Chief Executive Officer overseeing research, regulatory strategy, and patent development for the company's phage-based therapeutics platform.
JJ
John J WoloszynPresident & CEOJohn J Woloszyn trained as an attorney with experience in corporate law at large firms, focusing on capital formation and technology transfer in biotechnology, healthcare, and information technology sectors. He has founded multiple companies in biotechnology, healthcare, information technology, and web applications.
MR
Mel RuzickaExecutive
Board
GP
Gary PasterneckBoard director
PH
Patrick HervyBoard director
Reported raises · per SEC filings
Form D private placements$17.5M disclosed across 1 round · 2017
▶$17.5MraisedJun 2017 · 1 investors · OtherRule 506(b)
▶$17.5MraisedJun 2017 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Gary PasterneckDirector
- John J WoloszynExecutive Officer, Director
- Alexander SulakvelidzeExecutive Officer, Director
- Mel RuzickaExecutive Officer
- Patrick HervyDirector
- Offering amount
- $17.5M
- Amount sold
- $17.5M
- Proceeds to insiders
- $1.9M
- First sale
- May 2017
- Incorporated
- Corporation, Maryland
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 14 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $299.7K |
| Department of Agriculture (USDA) | Phase I | 2021 | $100K |
| Department of Agriculture (USDA) | Phase II | 2015 | $500K |
| Department of Agriculture (USDA) | Phase I | 2013 | $100K |
| Department of Agriculture (USDA) | Phase II | 2012 | $449.9K |
| U.S. ArmyArmy | Phase IISTTR | 2011 | $750K |
| Department of Agriculture (USDA) | Phase I | 2011 | $100K |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase ISTTR | 2009 | $100K |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase ISTTR | 2009 | $100K |
| U.S. ArmyArmy | Phase II | 2007 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2007 | $269.2K |
| U.S. ArmyArmy | Phase I | 2006 | $120K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2000 | $99.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded Intralytix?
- Intralytix was founded by Alexander Sulakvelidze.
- How much funding has Intralytix raised?
- Intralytix has disclosed $17.5M raised across 1 round.
- Where is Intralytix headquartered?
- Intralytix is headquartered in Baltimore, US.